Skip to main content

Advertisement

Log in

Apprising the choice of bariatric surgery in patients with compensated cirrhosis with morbid obesity: results of a national analysis

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

Bariatric surgery (BS) was proved safe in carefully selected patients with compensated cirrhosis (CC). However, limited data exist on differential impact of bariatric surgery type on clinical outcomes and health care utilization. This retrospective study utilizes the 2010–2014 Nationwide Readmissions Database. We included obese adults with CC who underwent the two most commonly used BS, Roux-en-Y (RYGB) and laparoscopic sleeve gastrectomy (LSG). Those with decompensation within 6 months of BS were excluded. Rates of hepatic decompensation (new-onset ascites, variceal bleed, encephalopathy, spontaneous bacterial peritonitis, and/or hepatorenal syndrome), surgical complications, health care utilization, and mortality were compared between RYGB and LSG. Multivariable analysis was performed to fit various models. A total of 3032 patients with CC underwent BS, including 1864 (61.5%) RYGB and 1168 (38.5%) LSG. The majority (56%) of BS were performed at large, metropolitan teaching hospitals. There were no significant differences in various decompensations and surgical complications comparing RYGB to LSG. Healthcare utilization including index length of stay (RYGB: 3.4 days vs LSG: 3.0 days), 30-day readmission rate (RYGB: 9.5% vs LSG: 3.7%), and cost of admission (RYGB: $14,006 vs LSG: $12,523) were higher in RYGB (p values < 0.001). Index admission and calendar year mortality could not be analyzed due to the few number of events. Two types of bariatric surgeries in obese patients with compensated cirrhosis have similar rates of decompensated cirrhosis events and surgical complications. However, RYGB procedure incurred increased healthcare utilization. Therefore, LSG may be the preferred BS for patients with CC. Prospective, randomized studies comparing the types of BS are needed to confirm our observations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets analyzed in this study are available from the Nationwide Readmissions Database.

References

  1. Calzadilla BL, Adams L (2016) The natural course of non-alcoholic fatty liver disease. Int J Mol Sci 17(5):774

    Article  Google Scholar 

  2. Vernon G, Baranova A, Younossi Z (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34(3):274–285

    Article  CAS  Google Scholar 

  3. Villareal D, Apovian C, Kushner R, Klein S (2005) Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 13(11):1849–1863

    Article  Google Scholar 

  4. Goh G, Schauer P, McCullough A (2018) Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol 24(28):3112–3119

    Article  Google Scholar 

  5. Vilar-Gomez E et al (2015) Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149:367–378

    Article  Google Scholar 

  6. Clanton J, Subichin M (2016) The effects of metabolic surgery on fatty liver disease and nonalcoholic steatohepatitis. Surg Clin North Am 96(4):703–715

    Article  Google Scholar 

  7. Lassailly G et al (2015) Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149(2):379–388

    Article  Google Scholar 

  8. Mummadi R, Kasturi K, Chennareddygari S, Sood G (2008) Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 6(12):1396–1402

    Article  Google Scholar 

  9. Reges O, Greenland P, Dicker D, Leibowitz M, Hoshen M, Gofer I, Balicer R (2018) Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA 319(3):279

    Article  Google Scholar 

  10. Helling TS, Helzberg JH, Nachnani JS et al (2008) Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Surg Obes Relat Dis 4:612–617

    Article  Google Scholar 

  11. Mosko J, Nguyen G (2011) Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 9(10):897–901

    Article  Google Scholar 

  12. Mumtaz K, Lipshultz K, Jalil S, Porter K, Li N, Kelly SG, Conteh LF, Michaels A, Hanje AJ, Black S, Hussan H (2020) Bariatric surgery in patients with cirrhosis: careful patient and surgery type selection is key to improving outcomes. Obes Surg 30(9):3444–3452

    Article  Google Scholar 

  13. Trastulli S, Desiderio J, Guarino S, Cirocchi R, Scalercio V, Noya G, Parisi A (2013) Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis 9(5):816–829

    Article  Google Scholar 

  14. Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer P, Brethauer S (2013) Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis 9(1):1–6

    Article  Google Scholar 

  15. NRD Overview. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD (2017). www.hcup-us.ahrq.gov/nrdoverview.jsp. Accessed Oct 2020

  16. Elixhauser A, Steiner C, Harris DR et al (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27

    Article  CAS  Google Scholar 

  17. Javanainen M, Penttilä A, Mustonen H, Juuti A, Scheinin T, Leivonen M (2017) A retrospective 2-year follow-up of late complications treated surgically and endoscopically after laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) for morbid obesity. Obes Surg 28(4):1055–1062

    Article  Google Scholar 

  18. Sippey M, Kasten K, Chapman W, Pories W, Spaniolas K (2016) 30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis 12(5):991–996

    Article  Google Scholar 

  19. Jan A, Narwaria M, Mahawar K (2015) a systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg 25(8):1518–1526

    Article  Google Scholar 

  20. Ma I, Madura J (2015) Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol 11(8):526–535

    Google Scholar 

  21. Chmielecki DK, Hagopian EJ, Kuo YH, Kuo YL, Davis JM (2012) Laparoscopic cholecystectomy is the preferred approach in cirrhosis: a nationwide, population-based study. HPB 14:848–853

    Article  Google Scholar 

  22. Trastulli S, Desiderio J, Guarino S, Cirocchi R, Scalercio V, Noya G, Parisi A (2013) Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 9(5):816–829. https://doi.org/10.1016/j.soard.2013.05.007

    Article  Google Scholar 

  23. Hollenbeak CS, Rogers AM, Barrus B, Wadiwala I, Cooney RN (2008) Surgical volume impacts bariatric surgery mortality: a case for centers of excellence. Surgery 144(5):736–743

    Article  Google Scholar 

  24. The Healthcare Cost and Utilization Project (HCUP), Limitations on Using the Nationwide Readmissions Database (NRD) (2020) https://www.hcup-us.ahrq.gov/db/nation/nrd/LimitationsonUsingtheNRD.pdf. Accessed Oct 2020

Download references

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Miller.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Research involving human participants and/or animals

Due to the Nationwide Readmission Database being a publicly available database of de-identified patients, our Institutional Review Board deemed this study exempt from approval.

Informed consent

Individual patient informed consent does not apply in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, A., Jalil, S., Hussan, H. et al. Apprising the choice of bariatric surgery in patients with compensated cirrhosis with morbid obesity: results of a national analysis. Updates Surg 73, 1899–1908 (2021). https://doi.org/10.1007/s13304-021-01142-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-021-01142-z

Keywords

Navigation